Methylprednisolone Hemisuccinate
Back to searchMolecule Structure
Scientific Name
Methylprednisolone Hemisuccinate
Description of the Drug
Methylprednisolone hemisuccinate is a water soluble corticosteroid used to treat severe allergic reactions, dermatologic diseases, endocrine disorders, gastrointestinal diseases, hematological disorders, neoplastic diseases, nervous system conditions, ophthalmic diseases, renal diseases, respiratory diseases, and rheumatic disorders.
Source: DrugBank Online – DrugBank.com. Retrieved 2023-03-10 from
http://www.drugbank.ca/drugs/DB14644
http://www.drugbank.ca/drugs/DB14644
Brand Name(s)
Not Available
Company Owner(s)
Tianjin Kingyork Pharmaceuticals Co Ltd, Fresenius Kabi Usa Llc, Hikma Farmaceutica Portugal Sa, Sagent Pharmaceuticals Inc, Hospira Inc, Watson Laboratories Inc, Abraxis Pharmaceutical Products, International Medication Systems Ltd, Teva Parenteral Medicines Inc, Eugia Pharma Specialities Ltd
Mechanism(s) Of Action
| Target Name | Target Type | Action Type | Target ChEMBL ID |
|---|---|---|---|
| Glucocorticoid receptor | SINGLE PROTEIN | AGONIST | CHEMBL2034 |
Clinical Trial(s)
Unichem Links
| SureChEMBL | SCHEMBL7915 | ||
| DrugBank | DB14644 | ||
| PubChem: Thomson Pharma | 144084094 | ||
| PubChem | 16923 | ||
| Nikkaji | J7.938C | ||
| EPA CompTox Dashboard | DTXSID80183466 | ||
| DrugCentral | 1771 | ||
| ChemicalBook | CB9478132 | ||
| rxnorm | SOLU-MEDROL | METHYLPREDNISOLONE SODIUM SUCCINATE | A-METHAPRED |
| ChEBI | 135765 | ||
| ZINC | ZINC000003977781 |
